Resources from the same session
375O - Final efficacy results from IMpower132: First-line atezolizumab + chemotherapy in patients with stage IV non-squamous NSCLC
Presenter: Makoto Nishio
Session: Proffered paper session on Thoracic cancers
Resources:
Abstract
Webcast
376O - Randomized, multicenter trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small cell lung cancer: NCT01631357
Presenter: Liang Liu
Session: Proffered paper session on Thoracic cancers
Resources:
Abstract
Slides
Webcast
377O - A randomized double-blind phase III study of niraparib versus placebo as maintenance therapy in extensive-stage small cell lung cancer
Presenter: Xinghao Ai
Session: Proffered paper session on Thoracic cancers
Resources:
Abstract
Slides
Webcast
LBA4 - GEMSTONE-302: A phase III study of platinum-based chemotherapy (chemo) with placebo or CS1001, an anti-PDL1 antibody, for first-line (1L) advanced non-small cell lung cancer (NSCLC)
Presenter: Caicun Zhou
Session: Proffered paper session on Thoracic cancers
Resources:
Abstract
Slides
Webcast
Invited Discussant abstracts LBA4 and 375O
Presenter: Martin Reck
Session: Proffered paper session on Thoracic cancers
Resources:
Slides
Webcast
Invited Discussant abstracts 376O and 377O
Presenter: Anne-Marie Dingemans
Session: Proffered paper session on Thoracic cancers
Resources:
Slides
Webcast
LIVE Q&A
Presenter: Linda Coate
Session: Proffered paper session on Thoracic cancers
Resources:
Webcast